Xpert MTB/RIF Assay Shortens Airborne Isolation for Hospitalized Patients With Presumptive Tuberculosis in the United States | Zendy

Christopher K. Lippincott | Zendy; M. B. Miller | Zendy; Elena B. Popowitch | Zendy; Colleen F. Hanrahan | Zendy; Annelies Van Rie | Zendy

Open Access

Xpert MTB/RIF Assay Shortens Airborne Isolation for Hospitalized Patients With Presumptive Tuberculosis in the United States

Author(s) -

Christopher K. Lippincott,

M. B. Miller,

Elena B. Popowitch,

Colleen F. Hanrahan,

Annelies Van Rie

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu212

Subject(s) - medicine , sputum , interquartile range , tuberculosis , mycobacterium tuberculosis , pulmonary tuberculosis , surgery , pathology

In the United States, individuals with presumptive pulmonary tuberculosis are placed in airborne infection isolation (AII) and assessed by smear microscopy on 3 respiratory specimens collected 8-24 hours apart. Xpert MTB/RIF assay (Xpert) on 1, 2, or 3 specimens may be more efficient for determining AII discontinuation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research